GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence
NCT02633982
·
clinicaltrials.gov ↗
UNKNOWN
Status
5000
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Sponsor
Japan Cardiovascular Research Foundation